Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - US2270461096 - Common Stock

86.56 USD
+2.75 (+3.28%)
Last: 8/22/2025, 8:00:53 PM
86.55 USD
-0.01 (-0.01%)
After Hours: 8/22/2025, 8:00:53 PM
Fundamental Rating

7

Overall CROX gets a fundamental rating of 7 out of 10. We evaluated CROX against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on CROX. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
In the past 5 years CROX has always been profitable.
Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

The Return On Assets of CROX (5.31%) is better than 66.00% of its industry peers.
CROX has a Return On Equity of 16.64%. This is in the better half of the industry: CROX outperforms 76.00% of its industry peers.
The Return On Invested Capital of CROX (24.29%) is better than 96.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CROX is significantly above the industry average of 11.02%.
The last Return On Invested Capital (24.29%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROIC 24.29%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX's Profit Margin of 5.72% is fine compared to the rest of the industry. CROX outperforms 70.00% of its industry peers.
CROX's Profit Margin has improved in the last couple of years.
The Operating Margin of CROX (24.24%) is better than 98.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
The Gross Margin of CROX (59.36%) is better than 78.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.70. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.70, CROX is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
The Debt to FCF ratio of CROX is 1.79, which is an excellent value as it means it would take CROX, only 1.79 years of fcf income to pay off all of its debts.
CROX's Debt to FCF ratio of 1.79 is amongst the best of the industry. CROX outperforms 82.00% of its industry peers.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
CROX has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: CROX underperforms 68.00% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Altman-Z 3.7
ROIC/WACC2.58
WACC9.42%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

CROX has a Current Ratio of 1.54. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX's Current ratio of 1.54 is on the low side compared to the rest of the industry. CROX is outperformed by 70.00% of its industry peers.
CROX has a Quick Ratio of 1.54. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, CROX is doing worse than 64.00% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.81%.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.64% yearly.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 2.04% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.29% yearly.
EPS Next Y-2.17%
EPS Next 2Y0.79%
EPS Next 3Y-0.62%
EPS Next 5Y2.84%
Revenue Next Year1.64%
Revenue Next 2Y2.32%
Revenue Next 3Y1.69%
Revenue Next 5Y2.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated cheaply with a Price/Earnings ratio of 6.48.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
CROX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.24.
CROX is valuated cheaply with a Price/Forward Earnings ratio of 6.48.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 96.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.82. CROX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.48
Fwd PE 6.48
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 90.00% of the companies listed in the same industry.
CROX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CROX is cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.15
EV/EBITDA 5.34
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y0.79%
EPS Next 3Y-0.62%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (8/22/2025, 8:00:53 PM)

After market: 86.55 -0.01 (-0.01%)

86.56

+2.75 (+3.28%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners101.38%
Inst Owner Change-3.39%
Ins Owners2.52%
Ins Owner Change5.82%
Market Cap4.73B
Analysts80
Price Target126.61 (46.27%)
Short Float %9.79%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.97%
Min EPS beat(2)3.5%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)11.28%
Min EPS beat(4)3.5%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)12.22%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)16
Avg EPS beat(16)15.25%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.22%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)6
Avg Revenue beat(12)0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)-2.43%
PT rev (3m)2.12%
EPS NQ rev (1m)-18.5%
EPS NQ rev (3m)-28.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.05%
Revenue NQ rev (1m)-7.65%
Revenue NQ rev (3m)-10.46%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 6.48
Fwd PE 6.48
P/S 1.14
P/FCF 6.15
P/OCF 5.65
P/B 3.33
P/tB N/A
EV/EBITDA 5.34
EPS(TTM)13.35
EY15.42%
EPS(NY)13.36
Fwd EY15.43%
FCF(TTM)14.08
FCFY16.26%
OCF(TTM)15.33
OCFY17.71%
SpS75.77
BVpS26.02
TBVpS-5.84
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROCE 26.86%
ROIC 24.29%
ROICexc 25.67%
ROICexgc 50.56%
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
FCFM 18.58%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Debt/EBITDA 1.28
Cap/Depr 92.37%
Cap/Sales 1.65%
Interest Coverage 11.92
Cash Conversion 77.72%
Profit Quality 325.08%
Current Ratio 1.54
Quick Ratio 0.97
Altman-Z 3.7
F-Score8
WACC9.42%
ROIC/WACC2.58
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
EPS Next Y-2.17%
EPS Next 2Y0.79%
EPS Next 3Y-0.62%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%
Revenue Next Year1.64%
Revenue Next 2Y2.32%
Revenue Next 3Y1.69%
Revenue Next 5Y2.29%
EBIT growth 1Y-6.14%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-1.52%
EBIT Next 3Y-1.8%
EBIT Next 5Y3.43%
FCF growth 1Y3.44%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-1.37%
OCF growth 3Y20.5%
OCF growth 5Y61.62%